James W. Kupiec's most recent trade in Cassava Sciences Inc was a trade of 4,000 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Nov. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cassava Sciences Inc | James Kupiec W. | Chief Medical Officer | 29 Nov 2024 | 4,000 | 0 (0%) | 0% | 3.9 | 15,480 | Common Stock | |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | 06 Sep 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | 20 May 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | ||
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | 18 Apr 2024 | 1,500 | 4,000 (0%) | 0% | 22 | 33,000 | Common Stock | |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | 18 Apr 2024 | 1,000 | 1,000 | - | - | Common Stock Warrant | ||
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | 18 Apr 2024 | 1,000 | 0 | - | - | Common Stock Warrant |